Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

L'influence de la dysrégulation immunitaire pré-transplantation sur les résultats de la greffe pour les immunodéficiences combinées et les troubles dysrégulateurs du système immunitaire

Études rétrospectives

Troubles héréditaires

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Thomas Fox & Emma Morris

The influence of pre-transplant immune dysregulation on transplant outcomes for combined immunodeficiencies and immune dysregulatory disorders

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Thomas Fox & Emma Morris

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN CARTILAGE HAIR HYPOPLASIA (CHH) A JOINT EBMT-CIBMTR STUDY

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Outcome of haematopoietic stem cell transplant (HSCT) in patients with Chediak Higashi syndrome

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Setting the stage for newborn screening and gene therapy: a disease-specific retrospective survey of FHL2 and 3

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Stephan Ehl, Despina Moshous, Claire Booth, Sujal Ghosh

Outcome of haploidentical transplant in chronic granulomatous disease

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Benedicte Neven

Late effects after hematopoietic stem cell transplantation in patients with HLH

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Inborn Errors Working Party (IEWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

AnnaCarin Horne

The outcome of second and third allogeneic conditioned HSCT in patients with non-SCID primary immune deficiency (PID) following primary or secondary graft failure

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

A prospective outcome study on patients with profound combined immune deficiency (p-CID)

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

HSCT experience in patients with Interferon gamma receptor deficiencies

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator